About Jason Leverone
Jason Leverone is a chief financial officer at OnKure Therapeutics.
Form D filings name Jason Leverone as an executive officer at OnKure.
Jason Leverone reports to the SEC as an officer of 2 public companies, including Viridian Therapeutics (VRDN).
Jason Leverone first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Leverone in the role, so the role may have started earlier or lasted longer.
OI
OnKure Therapeutics, Inc.
Chief Financial Officer
2024 – 2026 · Public company (OKUR)
VI
Viridian Therapeutics, Inc.
Chief Financial Officer
2017 – 2021 · Public company (VRDN)
Key Colleagues at Startups
The people Jason Leverone works with at each company, as listed on that company's latest Form D.
OnKure, Inc. · Form D, Apr 3, 2023
AP
Anthony Piscopio
Executive officer and director
RC
R. Carruthers
Director
AP
Andrew Phillips
Director
IM
Isaac Manke
Director
NS
Nicholas Saccomano
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
KO
Keith Olivia
Secretary